In this study, blood culture and PCR-microarray analysis were used to examine 172 cases of suspected septicemia. Primers and oligonucleotide probes, based on the sequences of bacterial 16SrRNA gene, were arrayed by imprinting on microarray slides. Blood specimens collected from 172 cases of suspected septicemia were cultured and then tested separately by PCR for the bacterial 16S rRNA. Of the 172 clinical cases, 17 cases tested positive by PCR. The number of positives identified by PCR (9.88%) was significantly higher than the number of positives identified by the blood culture (4.65%). When blood culture was used as control, the sensitivity of PCR was 100%, the specificity was 97.85%, and the index of accurate diagnosis was 0.979. When the 17 PCR positive specimens were further analyzed by hybridization against the microarrays, five were found to be probe positive for E. coli, four were positive for S. epidermidis, four were positive for CoNS, and two were positive for Bacillus and Propionibacterium, respectively. In the eight specimens showing positive results by both PCR and blood culture, the species determined by microarray analysis corresponded with the result obtained from blood culture. Detection of the bacterial 16SrRNA genes in clinical specimens by PCR and microarray analysis can be used to accurately diagnose neonatal sepsis. This method has a higher sensitivity and specificity than blood culture and can provide a rapid way for the etiological diagnosis of neonatal septicemia. Evaluation of patients with the signs and symptoms of bacterial sepsis requires a combination of clinical acumen and laboratory support. The diagnosis of bacterial infection can be particularly difficult in certain patients, such as neonates and young infants. Blood culture is widely used for the diagnosis of septicemia. However, in many clinical situations the yield from blood culture is low, positive cultures are obtained from fewer than 30%. Some of the patients with false-negative blood culture may have had prior antibiotic treatment or they were not bacteremic at the time of blood collection. In recent years, the sequence of the 16S rRNA gene has been used to detect and identify bacterial infection in clinical practice (1), but many of the PCR methods in use are not able to further differentiate between different bacterial species. DNA microarrays offer a means of enhancing the detection and identification capabilities of PCR. In this report, microarrays serve as a series of parallel dot-blots for rapid detection of sequence variation within the 16S rRNA gene and for detection of the products resulting from the PCR using conserved primers in the 16S rRNA gene. One hundred and ten strains of standard bacteria and corresponding clinical isolates were amplified by PCR and their products were further analyzed by DNA microarrays. Finally, we applied PCR amplification and microarray hybridization to assess clinical bacterial infection. We hypothesized that the PCR-microarray proves to be the most effective way of detecting bacteria in clinical practice and that it cannot only discover the existence of bacteria, but also identity the species and guide the clinical antibiotic selection.
Evaluation of patients with the signs and symptoms of bacterial sepsis requires a combination of clinical acumen and laboratory support. The diagnosis of bacterial infection can be particularly difficult in certain patients, such as neonates and young infants. Blood culture is widely used for the diagnosis of septicemia. However, in many clinical situations the yield from blood culture is low, positive cultures are obtained from fewer than 30%. Some of the patients with false-negative blood culture may have had prior antibiotic treatment or they were not bacteremic at the time of blood collection. In recent years, the sequence of the 16S rRNA gene has been used to detect and identify bacterial infection in clinical practice (1) , but many of the PCR methods in use are not able to further differentiate between different bacterial species. DNA microarrays offer a means of enhancing the detection and identification capabilities of PCR. In this report, microarrays serve as a series of parallel dot-blots for rapid detection of sequence variation within the 16S rRNA gene and for detection of the products resulting from the PCR using conserved primers in the 16S rRNA gene. One hundred and ten strains of standard bacteria and corresponding clinical isolates were amplified by PCR and their products were further analyzed by DNA microarrays. Finally, we applied PCR amplification and microarray hybridization to assess clinical bacterial infection. We hypothesized that the PCR-microarray proves to be the most effective way of detecting bacteria in clinical practice and that it cannot only discover the existence of bacteria, but also identity the species and guide the clinical antibiotic selection.
MATERIALS AND METHODS
Bacterial strains and clinical specimens. The 110 strains, including 26 genus and 48 species, used in this study are listed in Table 1 . For negative controls, we used total human DNA, cytomegalovirus (CMV), hepatitis B virus (HBV), EBV (EBV) and Cryptococcus neoformans (C. neoformans). One hundred seventy-two blood specimens from patients with suspected bacterial infections (sepsis and/or meningitis) (2) were evaluated by routine bacterial culturing and PCR-microarray hybridization. The study was approved by the Medical Ethics Committee of the Medical College, and informed consent was obtained. During the study period from January 1, 2004 to June 30, 2004, we included all neonates who were hospitalized in our neonatal ward and the NICU and developed clinical signs suggestive of sepsis after 3 d of life. These signs included: fever, temperature instability, apnea, dyspnea, cyanosis, respiratory distress, vomiting, abdominal distension, lethargy, irritability, hypoglycemia, hyperglycemia and excessive hyperbilirubinemia. In addition, 30 blood specimens from healthy neonates served as negative controls. The collection of blood samples from healthy children was done during the physical examination before entering kindergarten, which was approved by the provincial medical ethics committee. Bacteria were detected by culture of blood and PCR testing.
Primers and oligonucleotide-probe set. Eighteen oligonucleotide probes of 25-28 nucleotides in length, targeting the bacterial 16S rRNA, were selected from the rRNA database (http://www.ncbi.nlm.nih.gov). They included two universal probes, one Gram-positive probe, two Gram-negative probes, and other specific probes ( Table 2) . We also designed a pair of highly conserved primers based on a computer alignment of ribosomal RNA sequences available through GenBank. The sequence of the primers was as follows: upstream 5'-TGCGGTTGGATCAC-CTCCT-3', downstream 5'-TCCCCACCTTCCAGTT-3'.
DNA isolation. All bacterial strains were treated in 400 L of 5% Chelex100 buffer (containing 0.03% SDS, 1% Tween-20 and 1% NP40) and boiled for 15 min. DNA of each sample was collected and amplified from the supernatant. To lyse Staphylococcus, proteinase K was added to the 5% 
Note: * showed that one of them is ATCC or NCTC.
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Chelex100 buffer, and the mixture was incubated at 56°C for 60 min and then boiled for 15 min. Blood samples in the presence of EDTA were subjected to red cell lysis in five volumes of 0.87% NH 4 Cl, leukocytes were pelleted, suspended in 200 L of 5% Chelex100 buffer with 20 mg/mL proteinase K, incubated at 56°C for 60 min and then boiled for 15 min, centrifuged for 1 min, and the supernatant was collected for PCR amplification. PCR amplification. The PCR mixture (50 L) contained 50 mM Tris-HCl (pH 9.0), 50 mM KCl, 7 mM MgCl 2 , 2 mg/mL BSA, 16 mM (NH 4 ) 2 SO 4 , 100 M (of each) primer, and 1.0 U of Taq polymerase (Boehringer, Inc., Mannheim, Germany). The PCR mixture was incubated with 0.5 g of DNase I, which is active on double-stranded DNA (dsDNA, Boehringer, Mannheim, Inc., Germany) for 15 min at room temperature. The DNase was inactivated by incubating the mixture for 10 min at 95°C. The 5 L of the cell lysates, which contained the target DNA, was added to the PCR mixture. PCR was performed for 32 cycles of 1 min at 94°C, 15s at 55°C and 45 s at 72°C on a DNA thermocycler (Perkin-Elmer Cetus, Inc., Norwalk, CN). After amplification, the samples were incubated for another 5 min at 72°C.
Preparation of glass slides and spotting. The DNA microarray format used in this study is based on standard microscopic glass slides (CEL, Inc., USA). Slides were activated by 1,4-phenylenedisothiocyanate treatment for covalent binding of 5'-amino-modified capture oligonucleotides. Probes were spotted onto the activated slide surface with the spotting device robodrop (Cartesian, Inc., USA). The concentration of the amino-modified oligonucleotides in PCR-water was 10 M with 1% glycerol. Volumes of deposited probe solutions were about 250 pL, resulting in spots with a diameter of approximately 200 m. To complete covalent binding, after being spotted with probe solutions, slides were incubated at room temperature for 2 h in a wet chamber to prevent the evaporation of the spots. Blocking of the slides was performed in 6-amino-1-hexanol (50 mM) and diisopropylethylamine (150 mM) in dimethylformamide. Finally, the slides were washed with deionized, particlefree water, air dried, and stored under nitrogen at 4°C.
DNA microarray hybridization. Hybridization and washing of the microarrays were performed according to a standard protocol from the ArrayIt Handbook (http://www.arrayit.com). For hybridization to the array, we combined 8 L of the PCR products with 8 L of 5ϫSSPE, 1%SDS to a final volume of 16 L. This mixture was placed in a boiling water bath for 2 min, cooled on ice, then applied to the surface of a blocked and immobilized microarray that had been prewarmed to 48°C. The microarray and hybridization were overlayed with a coverslip and transferred to a prewarmed chamber that was kept humid by enclosing a folded paper towel moistened with 2ϫSSC. The array was incubated in 48°C for 1/2h. Then the array was washed at room temperature, first in 2ϫSSC, 0.01%SDS for 2min, then in 0.1ϫSSC, 0.01%SDS for 3min and finally in 0.01%SDS for 1min. Slides were dried at room temperature. Unless otherwise specified, probes were applied for hybridization experiments in the standard way, i.e., all probes immobilized via their 5' end and at the same concentration (10 M). For reducing steric hindrance capture probes carrying polyadenosine triphosphate spacers of 6, 9, 12, or 15 nucleotides, located at the 5' end of the capture oligonucleotide, were used.
Signal detection and data analysis. Air-dried slides were imaged at a resolution of 10 m with a ScanArray Express microarray scanner (PerkinElmer, Inc., Fremont, CA) using the same laser power and sensitivity level of the photomultiplier for each slide. Therefore, absolute signal intensities (arbitrary units) obtained from independent experiments should be directly comparable. For automatic spot detection and signal quantification, the ScanArray Express software was used. Filters for the automatic removal of spots with poor circularity or low uniformity of pixel intensities were established. Signals were considered positive if values were above zero after local background correction. This strategy for assessing the reliability of positive spots 
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was possible because nonspecific binding of labeled target molecules to the slide surface was not observed for regions where oligonucleotides were located. Blood culture. A total of 0.5 to 1.0 mL of blood was obtained from 172 selected patients with suspected septicemia by venipuncture under sterile conditions and inoculated into 20 mL of tryptone soya broth or thioglycolate broth for aerobic and anaerobic culture of organisms. The cultures were incubated at 35°C and inspected visually every morning. Subcultures were performed 14 to 18 h after inculcation. Samples were removed from each culture bottle aseptically with a sterile 1 mL syringe, and one drop was subcultured on duplicate blood agar and chocolate agar, which were then incubated at 35°C. One blood agar plate, along with the chocolate agar, was incubated in 5% CO 2 . The positive growth was recorded and biochemical tests were carried out to identify the bacteria from blood culture at 48 h to 72 h.
RESULTS
Specificity of universal primers and sensitivity of the PCR assay. To verify that the primers used in this study were specific for bacteria (110 species), human DNA, CMV, HBV, EBV and C. neoformans were tested. Amplified products of 371 bp were detected from bacterial DNA, but not from human DNA, CMV, HBV, EBV, and C. neoformans. Therefore, our primers did not cross-react with DNA from human, viruses and fungi, and were highly specific for bacteria. The sensitivity of detection of amplification with the universal primers was examined. Serial 10-fold dilutions of E. coli DNA were prepared and added to the reaction mixture. At 32 cycles, it was possible to reproducibly detect a band using concentrations equal to 1 pg of the E. coli 16S rRNA gene, which corresponds to the amount of DNA contained in approximately three organisms (3) .
General steric hindrance. Poly (T) spacers of different lengths (none, 3-mer, 6-mer, 9-mer, 12-mer, and 15-mer) were tested on universal probe 1. Oligonucleotide probes with polydT spacers of 0, 3, 6, 9, 12, or 15 nucleotide were synthesized and attached to slides. The hybridization signal was virtually nonexistent for polydT spacers of 3-mer or less, but then increased strongly with length up to 9-mer and kept higher signal from 9-mer to 15-mer. We selected 9-mer spacer as general spacer molecules.
Results of 16S rRNA gene PCR and bacterial culturing. Of 172 specimens with suspected septicemia, 17 (9.88%) were positive by PCR, while 8 specimens (4.65%) were positive by blood culture. The positive rate of PCR was significantly higher than that of blood culture (p Ͻ 0.01) ( Table 3) . Thirty blood samples from healthy children were confirmed to be negative by both blood culture and PCR. When blood culture was used as a control, the sensitivity of PCR was 100%, the specificity was 97.85%, and the index of accurately diagnosis was 0.979.
Microarray hybridization testing. The amplified products of expected size (371bp) were detected in 110 strains, including 55 Gram-positive and 55 Gram-negative strains. Using the amplified DNA of 55 Gram-positive bacteria as templets, there were positive findings for the two universal probes and the one Gram-positive probe. Two Gram-negative probes and two universal probes showed a positive result when 55 Gramnegative bacteria were used as templets. Each strain specifically hybridized with its own probe ( Fig. 1-3) .
The seventeen specimens with positive results by PCR were further hybridized on microarrays. All were positive by universal probes. Of those 17 specimens, five were positive by E. coli probe, four by S. epidermidis, four by CoNS, two by Bacillus and Propionibacterium, respectively. For the eight specimens positive by both PCR and blood culture, the species determined by microarray analysis corresponded to that determined by traditional blood culture (Table 4) .
DISCUSSION
Bacterial pathogens pose a significant threat to human health. Consequently, considerable effort has been devoted to the development of rapid, sensitive, and specific assays for the detection of these organisms. PCR is the most important molecular tool because of the potential for detecting less than 3 copies of a specific bacterium (1). Conventional PCR assays incorporate a pair of oligonucleotide primers to amplify a specific gene that is then detected using agarose gel electrophoresis combined with an intercalating dye (e.g., ethidium bromide) and UV light. If necessary, southern blots, dot-blots, or sequencing can be used to positively identify specific PCR products. The concept of DNA microarray hybridization was introduced recently, and the technique has been applied for a few years in clinical diagnosis and many fields of research, e.g., functional genomics and genetic analysis. In contrast, DNA microarrays are still not common in microbial diagnosis. Microarrays can be coupled with PCR where they serve as a set of parallel dot-blots to enhance products detection and identification (4 -8) . Microarray can be used to identify bacterial strains via reverse hybridization, as we have done it before (1). Microarrays are composed of many discretely located probes on glass. Each probe is composed of a sequence that is complimentary to a specific gene sequence. PCR is used to amplify DNA and the products are then hybridized to the array to identify different specific DNA. In a previous study (1), we have used the 16S rRNA gene to detect bacterial infection in neonatal septicemia. The method showed excellent specificity and sensitivity when applied to identify bacterial strains. In this study, we continued using the prior primers and amplified a 371 bp DNA fragment from 110 
